Why the study?
Does NT-proBNP assay accurately diagnose diastolic dysfunction, systolic dysfunction, and significant valve disorders in patients over 75 years?
Does NT-proBNP assay accurately diagnose diastolic dysfunction, systolic dysfunction, and significant valve disorders in patients over 75 years?
NT-proBNP has excellent negative predictive value for ruling out systolic dysfunction and significant valve disorders in very elderly patients, but is not useful for diagnosing diastolic dysfunction using standard echocardiography criteria.
Answers are grounded in this paper and cite their sources.
May support ruling out systolic dysfunction in very elderly; extends data but leaves open diastolic and valve roles.
OBJECTIVE: To evaluate the utility of N terminal pro brain natriuretic peptide (NT-proBNP) as a diagnostic marker for diastolic dysfunction or failure, systolic dysfunction, and significant valve disorders in patients over 75 years. DESIGN: Cohort study. SETTING: Outpatient echocardiography service in a district general hospital. PARTICIPANTS: 100 consecutive patients. MAIN OUTCOME MEASURES: Sensitivity, specificity, positive predictive values, negative predictive values, and area under receiver operating characteristic curve for NT-proBNP assay in the diagnosis of left ventricular diastolic dysfunction or failure, systolic dysfunction, and significant valve disorders. RESULTS: For diagnosis of systolic dysfunction NT-proBNP level of 424 pg/ml had a sensitivity of 96%, specificity of 45%, positive predictive value of 36%, and negative predictive value of 96%. The area under the curve was 0.71 (95% confidence intervals: 0.69 to 0.89). In valve heart disease, level of 227 pg/ml had sensitivity of 91%, specificity of 43%, positive predictive value of 40%, and negative predictive value of 92%. Patients with diastolic dysfunction/failure had lower plasma concentrations. CONCLUSIONS: This study showed that NT-proBNP had excellent negative predictive value for systolic dysfunction and significant valve disorders in very elderly patients. It increased significantly in systolic dysfunction, valve heart disease, and atrial fibrillation. NT-proBNP is not useful in the diagnosis of diastolic dysfunction or diastolic heart failure using standard echocardiography criteria.
No takes yet. Share an insight, caveat, or question.
Wellsted et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: